Show Summary Details
Page of

Lung cancer in non-smokers 

Lung cancer in non-smokers
Lung cancer in non-smokers

Spyridon Gennatas

and Sanjay Popat

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 January 2021

Lung cancer in non-smokers is a well recognised entity. Lung cancer in non-smokers is wholly associated with adenocarcinoma or variants thereof. A number of somatic molecular aberrations are observed in lung cancer recently, which has lead to various tailored treatment options based on clinical, molecular and genetic factors. TKI is an important option of treatment in lung cancer which has a role in the first-, second- and third-line management in selected group of lung cancer patients.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.